Amphastar, Momenta Antitrust Dispute Gets 2019 Trial Date
A federal judge in Boston said Thursday that he would allow Momenta and Sandoz to move again for dismissal in an antitrust dispute with Amphastar over a generic blood-clotting drug, and,...To view the full article, register now.
Already a subscriber? Click here to view full article